Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients. [electronic resource]
- Journal of critical care 12 2016
- 259-264 p. digital
Publication Type: Comparative Study; Journal Article; Observational Study
1557-8615
10.1016/j.jcrc.2016.06.026 doi
APACHE Adolescent Adult Aged Aged, 80 and over Antineoplastic Agents--adverse effects Aspergillus Autoimmune Diseases--drug therapy Biomarkers Bronchoalveolar Lavage Fluid--chemistry Critical Illness Early Diagnosis Female Galactose--analogs & derivatives Graft Rejection--prevention & control Humans Immunocompromised Host Immunosuppressive Agents--adverse effects Intensive Care Units Invasive Pulmonary Aspergillosis--complications Length of Stay Male Mannans--metabolism Middle Aged Mortality Neoplasms--drug therapy Neutropenia--complications Organ Dysfunction Scores Organ Transplantation Respiration, Artificial Respiratory Insufficiency--diagnosis Retrospective Studies Sensitivity and Specificity Young Adult beta-Glucans--blood